China has given the go-ahead for a treatment to treat covid-19, the Chinese Medicines Agency announced.
Unlike a preventive vaccine, the treatment is intended to treat the infected to avoid complications.
The Chinese Medicines Agency has announced that it is giving "emergency approval" to the Chinese treatment against Covid-19.
The drug is based on monoclonal antibodies that bind to the spike protein of the coronavirus, reducing its ability to penetrate cells.
Clinical trials show that the drug reduces the risk of hospitalization and death in patients who may develop a more severe form of covid-19.
In China, which only allows the use of domestic vaccines, more than 70 percent of the population has been vaccinated. 83 new cases of infection were reported in the country today.
Bonus video:
